Taiwan · Delayed Price · Currency is TWD Hantech Bio-Technology Statistics
Total Valuation
TPEX:1294 has a market cap or net worth of TWD 2.50 billion. The enterprise value is 2.29 billion.
| Market Cap | 2.50B |
| Enterprise Value | 2.29B |
Important Dates
The next estimated earnings date is Thursday, May 14, 2026.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | Jul 15, 2025 |
Share Statistics
TPEX:1294 has 30.23 million shares outstanding. The number of shares has increased by 4.66% in one year.
| Current Share Class | 30.23M |
| Shares Outstanding | 30.23M |
| Shares Change (YoY) | +4.66% |
| Shares Change (QoQ) | -1.37% |
| Owned by Insiders (%) | 25.32% |
| Owned by Institutions (%) | n/a |
| Float | 14.27M |
Valuation Ratios
The trailing PE ratio is 18.22.
| PE Ratio | 18.22 |
| Forward PE | n/a |
| PS Ratio | 3.21 |
| PB Ratio | 3.00 |
| P/TBV Ratio | 3.03 |
| P/FCF Ratio | 17.22 |
| P/OCF Ratio | 15.56 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.87, with an EV/FCF ratio of 15.81.
| EV / Earnings | 16.50 |
| EV / Sales | 2.95 |
| EV / EBITDA | 10.87 |
| EV / EBIT | 13.27 |
| EV / FCF | 15.81 |
Financial Position
The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.16.
| Current Ratio | 2.40 |
| Quick Ratio | 1.93 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 0.62 |
| Debt / FCF | 0.90 |
| Interest Coverage | 58.11 |
Financial Efficiency
Return on equity (ROE) is 16.83% and return on invested capital (ROIC) is 22.35%.
| Return on Equity (ROE) | 16.83% |
| Return on Assets (ROA) | 9.46% |
| Return on Invested Capital (ROIC) | 22.35% |
| Return on Capital Employed (ROCE) | 18.81% |
| Weighted Average Cost of Capital (WACC) | 2.47% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 152 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 5.48 |
Taxes
In the past 12 months, TPEX:1294 has paid 33.93 million in taxes.
| Income Tax | 33.93M |
| Effective Tax Rate | 19.61% |
Stock Price Statistics
The stock price has increased by +4.28% in the last 52 weeks. The beta is -0.32, so TPEX:1294's price volatility has been lower than the market average.
| Beta (5Y) | -0.32 |
| 52-Week Price Change | +4.28% |
| 50-Day Moving Average | 81.49 |
| 200-Day Moving Average | 77.29 |
| Relative Strength Index (RSI) | 53.30 |
| Average Volume (20 Days) | 37,248 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:1294 had revenue of TWD 778.54 million and earned 139.05 million in profits. Earnings per share was 4.54.
| Revenue | 778.54M |
| Gross Profit | 288.90M |
| Operating Income | 172.98M |
| Pretax Income | 173.01M |
| Net Income | 139.05M |
| EBITDA | 211.15M |
| EBIT | 172.98M |
| Earnings Per Share (EPS) | 4.54 |
Balance Sheet
The company has 339.38 million in cash and 131.37 million in debt, with a net cash position of 208.01 million or 6.88 per share.
| Cash & Cash Equivalents | 339.38M |
| Total Debt | 131.37M |
| Net Cash | 208.01M |
| Net Cash Per Share | 6.88 |
| Equity (Book Value) | 832.23M |
| Book Value Per Share | 27.30 |
| Working Capital | 345.06M |
Cash Flow
In the last 12 months, operating cash flow was 160.63 million and capital expenditures -15.45 million, giving a free cash flow of 145.19 million.
| Operating Cash Flow | 160.63M |
| Capital Expenditures | -15.45M |
| Depreciation & Amortization | 38.17M |
| Net Borrowing | -58.50M |
| Free Cash Flow | 145.19M |
| FCF Per Share | 4.80 |
Margins
Gross margin is 37.11%, with operating and profit margins of 22.22% and 17.86%.
| Gross Margin | 37.11% |
| Operating Margin | 22.22% |
| Pretax Margin | 22.22% |
| Profit Margin | 17.86% |
| EBITDA Margin | 27.12% |
| EBIT Margin | 22.22% |
| FCF Margin | 18.65% |
Dividends & Yields
This stock pays an annual dividend of 2.91, which amounts to a dividend yield of 3.51%.
| Dividend Per Share | 2.91 |
| Dividend Yield | 3.51% |
| Dividend Growth (YoY) | 213.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 62.88% |
| Buyback Yield | -4.66% |
| Shareholder Yield | -1.14% |
| Earnings Yield | 5.56% |
| FCF Yield | 5.81% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 31, 2025. It was a forward split with a ratio of 1.10082303.
| Last Split Date | Jul 31, 2025 |
| Split Type | Forward |
| Split Ratio | 1.10082303 |
Scores
TPEX:1294 has an Altman Z-Score of 6.03 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.03 |
| Piotroski F-Score | 5 |